Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine
Mert Öztaş(Istanbul University-Cerrahpaşa), Serdal Uğurlu(Istanbul University), Sarvan Aghamuradov(Istanbul University), Ayten Dağ(Istanbul University-Cerrahpaşa), Günay Can(Istanbul University-Cerrahpaşa), Murat Bektaş(Istanbul University), Ahmet Gül(Istanbul University), Emire Seyahi(Istanbul University), İlker Karacan(Istanbul Medeniyet University), Selma Sarı(Istanbul University), Murat Bolayırlı(Istanbul University-Cerrahpaşa), N. Aliyeva(Istanbul University), Huri Özdoğan, Gülen Hatemi(Istanbul University), Selim Berke Cevirgen(Istanbul University-Cerrahpaşa)
Cited by 8
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
EULAR recommendations for the management of familial Mediterranean fever
|Annals of the Rheumatic Diseases|2016|593
Behçet syndrome: a contemporary view
|Nature Reviews Rheumatology|2018|438
Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.
|Annals of the Rheumatic Diseases|1984|409